180 related articles for article (PubMed ID: 16884393)
21. [Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)].
Sebert JL; Fournier A; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
Nouv Presse Med; 1977 Nov; 6(37):3419-24. PubMed ID: 341075
[No Abstract] [Full Text] [Related]
22. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
Sato T
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
[TBL] [Abstract][Full Text] [Related]
23. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.
Libbey NP; Chazan JA; London MR; Pono L; Abuelo JG
Clin Nephrol; 1993 Apr; 39(4):214-23. PubMed ID: 8491052
[TBL] [Abstract][Full Text] [Related]
24. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
[TBL] [Abstract][Full Text] [Related]
25. [Pathological analysis of renal osteodystrophy in 194 cases].
Yu YF
Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
[TBL] [Abstract][Full Text] [Related]
26. [Pathophysiology and treatment of renal osteodystrophy].
Ionova D
Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
[No Abstract] [Full Text] [Related]
27. Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?
Teitelbaum SL; Bergfeld MA; Freitag J; Hruska KA; Slatopolsky E
J Clin Endocrinol Metab; 1980 Aug; 51(2):247-51. PubMed ID: 6893204
[No Abstract] [Full Text] [Related]
28. Calcium and phosphorus in diet therapy of uremia.
Schoolwerth AC; Engle JE
J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
[TBL] [Abstract][Full Text] [Related]
29. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
30. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
31. Azotaemic renal osteodystrophy: a quantitative study on iliac bone.
Ellis HA; Peart KM
J Clin Pathol; 1973 Feb; 26(2):83-101. PubMed ID: 4696838
[TBL] [Abstract][Full Text] [Related]
32. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
Chan JC; Kodroff MB; Landwehr DM
Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
[TBL] [Abstract][Full Text] [Related]
33. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
[TBL] [Abstract][Full Text] [Related]
34. Bone aluminum and histomorphometric features of renal osteodystrophy.
Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
[TBL] [Abstract][Full Text] [Related]
35. Renal osteodystrophy: some new questions on an old disorder.
Lee DB; Goodman WG; Coburn JW
Am J Kidney Dis; 1988 May; 11(5):365-76. PubMed ID: 3285668
[TBL] [Abstract][Full Text] [Related]
36. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
[TBL] [Abstract][Full Text] [Related]
37. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
[TBL] [Abstract][Full Text] [Related]
38. The pathophysiology and management of renal bone disease in dialysis patients.
Meers C; Morton AR; Toffelmire EB
CANNT J; 1999; 9(2):24-9, 32-8; quiz 30-1, 39-40. PubMed ID: 11778255
[TBL] [Abstract][Full Text] [Related]
39. Renal osteodystrophy.
Hruska KA
Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):165-94. PubMed ID: 9222491
[TBL] [Abstract][Full Text] [Related]
40. [Etiology and pathology of metabolic bone diseases: renal osteodystrophy].
Shigematsu T; Ogura Y
Nihon Rinsho; 1986 Nov; 44(11):2428-36. PubMed ID: 3546796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
